News High Levels of Pro-Inflammatory Immune Cells in Intestines May Promote MS Activity, Study Reports High Levels of Pro-Inflammatory Immune Cells in Intestines May Promote MS Activity, Study Reports by Patricia Inacio, PhD | July 14, 2017 Share this article: Share article via email Copy article link People with multiple sclerosis have high levelsĀ of pro-inflammatory TH17 immune cells in their intestines that correlate with change in the micro-organism mix in their gut and the levels of their disease activity, a study reports. Researchers said the findings suggest that diet, probiotics and therapies that regulate TH17 cells could help treat MS. Probiotics are supplements containing beneficial bacteria. The study, āHigh frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis,ā was published in the journal Science. Research has shown that TH17 cells, also known as T helper 17 cells, play a role in the development of Ā MS. In fact, they were the first harmfulĀ immune T-cells to infiltrate the central nervous system, according to studies in animals Where TH17 cells become activated has been unclear, however.Ā Studies in mice suggested it was mainly in the small intestine. Research has also indicated that their activation increases the potential for a person to develop an autoimmune brain disease like multiple sclerosis. An autoimmune disease occurs when the immune system, which defends the body against disease, decides that a person’s healthy cells are foreign, and attacks those cells. Researchers decided to see if the findings in mouse models of MS applied to people with the disease. They discovered a link between higher levels ofĀ TH17 cells in MS patients’ intestines and autoimmune brain problems. They alsoĀ found a correlation between higher levels of TH17 cells and changes in patients’ gut microbiome. The team then identified which bacteria were changing in the gut. Patients with increased levels of TH17 cells and higher disease activity had a higher ratio of Firmicutes to Bacteroidetes bacteria and moreĀ StreptococcusĀ strains in their gut, particularlyĀ Streptococcus mitisĀ andĀ StreptococcusĀ oralis. Previous studies have shown that these species promote TH17 cell differentiation in humans. Cell differentiation involves a cell transforming from one cell type to another ā usually a more specialized type. This dramatically changes a cell’s size, shape, metabolic ā or fuel-burning ā activity, and responsiveness to signals. Some studies have suggested a link between T-cell differentiation and brain autoimmune diseases. āOn the basis of our findings, we speculate that, under certain conditions, or because of still unknown virulence factors, theseĀ StreptococcusĀ strains can colonize the small intestine and favor TH17 cell differentiation in the human gut mucosa [linings],ā researchers wrote. In addition to moreĀ StreptococcusĀ bacteria, the team detected lower levels ofĀ Prevotella bacteria in MS patients with disease activity than in healthy controls or patients with no disease activity.Ā This decrease may also promote TH17 cell differentiation because āPrevotellaĀ is capable of producing the anti-inflammatory metabolite propionate that limits intestinal TH17 cell expansion in mice,” the researchers wrote. Overall, the team concluded that āour data demonstrate that brain autoimmunity is associated with specific microbiota modifications and excessive TH17 cell expansion in the human intestine.ā The findings suggest that regulating TH17 cell expansion, along with changes in diet aimed at regulating intestinal linings, could be ways to help treat MS. Print This Page About the Author Patricia Inacio, PhD Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship. Tags diet, disease activity, gut microbiome, probiotics, Th17
April 18, 2024 News by Marisa Wexler, MS AAN 2024: Sustained myelin, nerve cell gains with long-term CNM-Au8
April 17, 2024 News by Marisa Wexler, MS AAN 2024: Fertility treatment in MS doesn’t increase relapse risk
April 17, 2024 News by Steve Bryson, PhD NfL blood levels predict CIS to MS conversion: Clinical trial data